Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

127
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
127
Transcytosis of IgG01:15

Transcytosis of IgG

4.5K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.5K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

885
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
885
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

15.5K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.5K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

306
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
306
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

115
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
115

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management of systemic lupus erythematosus-Including secondary antiphospholipid syndrome, fertility and pregnancy : S3 guidelines of the German Society for Rheumatology and Clinical Immunology and the German Society for Neurology (DGN), German Society for Internal Medicine (DGIM), German Cardiac Society (DGK), Society for Thrombosis and Hemostasis Research (GTH), German Society for Hematology and Medical Oncology (DGHO), German Society for Pediatric and Adolescent Medicine (DGKJ), Society for Pediatric and Adolescent Rheumatology (GKJR), German Society for Nephrology (DGfN), German Society for Pneumology and Ventilation Medicine (DGP), German Rheumatism League National Association, Lupus Erythematosus Self-help Community, German Dermatological Society (DDG). Version:Ā 1.2].

Zeitschrift fur RheumatologieĀ·2025
Same author

Castleman's disease in the rheumatological practice.

Zeitschrift fur RheumatologieĀ·2024
Same author

[Castleman's disease in the rheumatological practice].

Zeitschrift fur RheumatologieĀ·2023
Same author

[Further development of regional early care-Many roads lead to Rome : Developmental stages of four established rheumatological early care concepts in different regions of Germany].

Zeitschrift fur RheumatologieĀ·2022
Same author

[Development of quality standards for patients with rheumatoid arthritis for use in Germany].

Zeitschrift fur RheumatologieĀ·2021
Same author

[Development of quality standards for patients with axial spondyloarthritis for use in Germany].

Zeitschrift fur RheumatologieĀ·2021
Same journal

[Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

Zeitschrift fur RheumatologieĀ·2026
Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur RheumatologieĀ·2026
Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: aĀ response.

Zeitschrift fur RheumatologieĀ·2026
Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur RheumatologieĀ·2026
Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur RheumatologieĀ·2026
Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur RheumatologieĀ·2026
See all related articles

Related Experiment Video

Updated: Mar 23, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

11.0K

[Cryoglobulinemic vasculitis].

N Blank1, H-M Lorenz2

  • 1Medizinische Klinik 5, Sektion Rheumatologie, Im Neuenheimer FeldĀ 410, 69120, Heidelberg, Deutschland. norbert.blank@med.uni-heidelberg.de.

Zeitschrift Fur Rheumatologie
|April 2, 2016
PubMed
Summary
This summary is machine-generated.

Cryoglobulinemic vasculitis affects small arteries and can cause severe impairment, even with low cryoglobulin levels. Early recognition of symptoms is key for diagnosis and treatment of this complex condition.

Keywords:
CryoglobulinsGlucocorticoidsMonoclonalPolyclonalRituximab

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.9K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.1K

Related Experiment Videos

Last Updated: Mar 23, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

11.0K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.9K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.1K

Area of Science:

  • Rheumatology
  • Nephrology
  • Hematology

Background:

  • Cryoglobulinemic vasculitis is a small-vessel vasculitis impacting multiple organs.
  • Low levels of cryoglobulins can cause significant patient impairment.
  • Diagnosis can be challenging due to the difficulty in detecting low cryoglobulin concentrations.

Purpose of the Study:

  • To highlight the importance of recognizing clinical symptoms for early diagnosis.
  • To outline the diagnostic challenges and necessary investigations.
  • To discuss current therapeutic strategies and their basis.

Main Methods:

  • Review of clinical presentation and diagnostic workup for cryoglobulinemic vasculitis.
  • Analysis of underlying causes, including hematological diseases, autoimmune disorders, and infections.
  • Evaluation of treatment modalities based on disease severity and underlying etiology.

Main Results:

  • Typical clinical symptoms are crucial for initiating appropriate laboratory diagnostic procedures.
  • Detection of low cryoglobulin levels presents a diagnostic hurdle.
  • Treatment requires addressing the underlying cause and may involve glucocorticoids, rituximab, or plasmapheresis.

Conclusions:

  • Prompt recognition of clinical signs is essential for timely diagnosis of cryoglobulinemic vasculitis.
  • Management strategies are tailored to the individual patient's condition and underlying causes.
  • Treatment recommendations are often based on registry data due to limited clinical trials.